Drug Discovery Pipeline;
Guangzhou Institutes of Biomedicine and Health;
Science City;
Guangzhou;
China;
Institute of Chemical Biology;
Guangzhou Institutes of Biomedicine and Health;
Chinese Academy of Sciences;
Guangzhou;
China;
University of Chinese Academy of Sciences;
Beijing;
China;
BENZAMIDES; NUCLEOPROTEIN; ANTI-INFLUENZA; NP Inhibitors; Nucleozin;